whole grape extract: Clinical Trials

3 trials of whole grape extract, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 31Completed 1

Follow whole grape extract: new trials by email Literature Review of whole grape extract trials Research Report on whole grape extract

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Grape Consumption on Brain Metabolism and Neuropsychological Performance Over 1 Year
Grape Powder, Placebo Powder - Mild Cognitive Impairment
Phase 2CompletedUniversity of California, Los Angeles322017-11-182023-02-21
Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress
Pterostilbene 50 mg twice daily, Placebo, Grape Extract - Hyperlipidemia, Blood Pressure
Phase 2 / Phase 3CompletedUniversity of Mississippi Medical Center802010-12-012018-01-10
Resveratrol-enriched Grape Extract (Stilvid) in Primary and Secondary Prevention of Cardiovascular Disease
Placebo in primary cardiovascular prevention (PP), Placebo in secondary prevention, Grape extract in primary prevention (PP) - Cardiovascular Diseases
Phase 2CompletedNational Research Council, Spain1502009-04-012011-11-16

Conditions studied

Alzheimer Disease (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cognitive Dysfunction (1)  ·  Dementia (1)  ·  Hyperlipidemias (1)

Sponsors

National Research Council, Spain (1)  ·  University of California, Los Angeles (1)  ·  University of Mississippi Medical Center (1)

Countries

United States (2)  ·  Spain (1)

Top investigators

Daniel H Silverman, MD, PhD (1)  ·  Daniel M Riche, Pharm.D. (1)

Results publications

PMID 23431291, PMID 25057276